Tomonori Mizutani

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo et al. · The Lancet · 2023 · 891 citations · Full text

Urology, Surgical Oncology, Gastrointestinal Oncology +5

Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial

Takashi Onda, Toyomi Satoh, Gakuto Ogawa et al. · European Journal of Cancer · 2020 · 207 citations

Gynecologic Surgery, Surgical Oncology, Gynecological Surgery +10

Prognostic impact of a ground-glass opacity component in clinical stage IA non–small cell lung cancer

Aritoshi Hattori, Kenji Suzuki, Kazuya Takamochi et al. · Journal of Thoracic and Cardiovascular Surgery · 2020 · 174 citations · Full text

Prognostic Impact, Oncologic Imaging, Ground-glass Opacity Component +7

A non-randomized confirmatory trial of segmentectomy for clinical T1N0 lung cancer with dominant ground glass opacity based on thin-section computed tomography (JCOG1211)

Keiju Aokage, Hisashi Saji, Kenji Suzuki et al. · General Thoracic and Cardiovascular Surgery · 2017 · 107 citations

Computed Tomography, Non-randomized Confirmatory Trial, Oncologic Imaging +8

The international collaboration of active surveillance trials for low-risk DCIS (LORIS, LORD, COMET, LORETTA).

Chizuko Kanbayashi, Alastair M. Thompson, Eun-Sil Shelley Hwang et al. · Journal of Clinical Oncology · 2019 · 75 citations

Surgical Oncology, Breast Oncology, Cancer Management +22